{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:10:30Z","timestamp":1789013430325,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rabies remains a major public health concern in endemic countries, particularly among children. Simplified pre-exposure prophylaxis (PrEP) schedules may improve feasibility and access in resource-limited settings and facilitate the integration of rabies vaccination into routine childhood immunization, school-based and community-based vaccination programs in rabies-endemic regions. However, pediatric data on single-visit, 2-site intradermal PrEP regimens remain limited. This study evaluated the immunogenicity and safety of a single-visit, 2-site intradermal rabies PrEP regimen in children 1\u201318 years of age on days 28 and 180.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective single-arm study enrolled healthy children 1\u201318 years old at a tertiary care center. Participants received a single-visit, 2-site intradermal rabies PrEP regimen with a Vero cell culture rabies vaccine (RABIVAX-S\u00ae). Anti-rabies glycoprotein immuglobulin G antibody concentrations were measured using enzyme-linked immunosorbent assay, and rabies virus neutralizing antibody concentrations were estimated by Rapid Fluorescent Focus Inhibition Test at baseline, day 28 and day 180. Participants with rabies virus neutralizing antibody concentrations &lt;0.5 IU\/mL at day 28 or day 180 received 2 intradermal booster doses on days 0 and 3 after laboratory results became available and participants returned for follow-up, followed by repeat antibody assessment 7 days after the first booster dose. The primary outcome was seroprotection (\u22650.5 IU\/mL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty-eight children were enrolled, of whom 44 were evaluated on day 28. The enrolled cohort comprised participants 2\u201315 years old. On day 28, 40\/44 (90.9%) achieved protective antibody concentrations (\u22650.5 IU\/mL). Among 40 participants included in the day 180 analysis, 27 (67.5%) maintained protective concentrations. All participants with insufficient concentrations (n = 4 on day 28, n = 13 on day 180) demonstrated robust anamnestic responses following booster administration, achieving 100% seroprotection within 7 days. The regimen was well tolerated, with only mild local adverse events reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Single-visit, 2-site intradermal rabies PrEP demonstrated high early seroprotection and preserved immunologic priming despite declining antibody concentrations at 6 months. These findings support further evaluation of simplified pediatric PrEP regimens in larger controlled studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005407","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:01:17Z","timestamp":1789012877000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity of Single-visit, Two-site Intradermal Pre-exposure Rabies Prophylaxis in Children"],"prefix":"10.1097","author":[{"given":"Anurag","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Maulana Azad Medical College & Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanvi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Maulana Azad Medical College & Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-5036","authenticated-orcid":false,"given":"Surendra Bahadur","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Postgraduate Institute of Child Health, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Manchanda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Maulana Azad Medical College & Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7657-4199","authenticated-orcid":false,"given":"Padinjaremattathil Thankappan","family":"Ullas","sequence":"additional","affiliation":[{"name":"Rabies Laboratory, Encephalitis Group, ICMR \u2013 National Institute of Virology, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Sharma","sequence":"additional","affiliation":[{"name":"State Level VRDL, Department of Microbiology, Maulana Azad Medical College & Associated Hospitals, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"R1-20260910","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies.","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260910","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies.","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"R7-20260910","first-page":"201","article-title":"Rabies vaccines: WHO position paper, April 2018.","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"R9-20260910","doi-asserted-by":"crossref","first-page":"102612","DOI":"10.1016\/j.tmaid.2023.102612","article-title":"Single visit rabies pre-exposure prophylaxis: a literature review.","volume":"54","author":"Damanet","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R10-20260910","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(76)93028-2","article-title":"Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses.","volume":"1","author":"Turner","year":"1976","journal-title":"Lancet"},{"key":"R11-20260910","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/BF01713059","article-title":"High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies.","volume":"64","author":"Tauber","year":"1986","journal-title":"Klin Wochenschr"},{"key":"R12-20260910","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies preexposure vaccination schedules.","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"key":"R13-20260910","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1473-3099(23)00452-8","article-title":"Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial.","volume":"24","author":"Overduin","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R14-20260910","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciy983","article-title":"Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination.","volume":"69","author":"Soentjens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R15-20260910","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab059","article-title":"Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers.","volume":"28","author":"Mills","year":"2021","journal-title":"J Travel Med"},{"key":"R16-20260910","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.vaccine.2011.12.028","article-title":"One clinic visit for pre-exposure rabies vaccination (a preliminary one year study).","volume":"30","author":"Khawplod","year":"2012","journal-title":"Vaccine"},{"key":"R17-20260910","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age.","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"R18-20260910","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa006","article-title":"Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.","volume":"27","author":"Furuya-Kanamori","year":"2020","journal-title":"J Travel Med"},{"key":"R19-20260910","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax033","article-title":"Single-visit rabies pre-exposure priming induces a robust anamnestic antibody response after simulated post-exposure vaccination: results of a dose-finding study.","volume":"24","author":"Jonker","year":"2017","journal-title":"J Travel Med"},{"key":"R20-20260910","doi-asserted-by":"crossref","first-page":"126878","DOI":"10.1016\/j.vaccine.2025.126878","article-title":"Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: a systematic review and meta-analyses.","volume":"53","author":"Davis","year":"2025","journal-title":"Vaccine"},{"issue":"suppl","key":"R21-20260910","first-page":"S37","article-title":"Market mapping and landscape analysis of human rabies biologicals in India.","volume":"63","author":"Sudarshan","year":"2019","journal-title":"Indian J Public Health"},{"issue":"suppl","key":"R22-20260910","first-page":"S26","article-title":"Facilities and services of postexposure prophylaxis in anti-rabies clinics: a national assessment in India.","volume":"63","author":"Sudarshan","year":"2019","journal-title":"Indian J Public Health"},{"key":"R24-20260910","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"R25-20260910","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab060","article-title":"Diagnostic accuracy of ELISA kits for measurement of rabies antibodies.","volume":"28","author":"Ling","year":"2021","journal-title":"J Travel Med"},{"key":"R26-20260910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40794-025-00262-3","article-title":"One-step ahead: evaluating the efficacy of single-visit rabies pre-exposure prophylaxis against conventional multi-visit protocol: a randomized non-inferiority clinical trial.","volume":"11","author":"Singh","year":"2025","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"suppl 3","key":"R27-20260910","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.ejcn.1601492","article-title":"Nutrition and the immune system from birth to old age.","volume":"56","author":"Chandra","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"R28-20260910","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases.","volume":"11","author":"Narayana","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R29-20260910","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.","volume":"24","author":"Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"R30-20260910","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s15010-025-02623-8","article-title":"Immunogenicity and safety of the accelerated 2-dose intradermal rabies pre exposure prophylaxis regimen in immunocompetent and immunocompromised pediatric populations: a comparative study.","volume":"53","author":"Agarwal","year":"2025","journal-title":"Infection"},{"key":"R31-20260910","first-page":"32","article-title":"An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey.","volume":"38","author":"Sudarshan","year":"2006","journal-title":"J Commun Dis"},{"key":"R32-20260910","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2009.09.027","article-title":"Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania.","volume":"27","author":"Shim","year":"2009","journal-title":"Vaccine"},{"key":"R33-20260910","doi-asserted-by":"crossref","first-page":"126703","DOI":"10.1016\/j.vaccine.2024.126703","article-title":"Routine childhood rabies pre-exposure prophylaxis can be cost effective in low- and middle-income countries.","volume":"47","author":"Ritchie","year":"2025","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:01:21Z","timestamp":1789012881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005407"}},"subtitle":["A Prospective Interventional Study"],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005407","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}